A revolution in feline diabetes mellitus care! Novel drugs and new…

Presented by Susan Little, DVM, Dipl. ABVP

Continuing education questionnaire

CE credit: 1

AssignedWebcast

Name

First name *

Last name *

License number *

Province where you practise *

Email *

Questions

1. Which of the following statements is false? *

Multimorbidity is common in senior cats

Our priorities for a patient always align with the owner’s priorities

Health literacy is a challenge for owners

2. Which of the following is an important component of intensive management with insulin? *

The patient is newly diagnosed

The patient is less than 8 years of age

The patient weighs less than 7 kg

3. Which of the following is associated with “loose” insulin management protocols? *

Blood glucose curves are not necessary

The cost is the same as for standard management protocols

Remission is highly likely within 4 weeks

4. Which of the following is not associated with diabetes management foods? *

Improved glycemic control

Lower insulin doses

Increased chance of remission

5. Sodium-glucose cotransporter-2 (SGLT2) inhibitor drugs control hyperglycemia by: *

Promoting glucose absorption in renal tubules

Completely blocking glucose reabsorption in renal tubules

Promoting urinary glucose excretion

6. Which of the following adverse effects is rare when using SGLT2 inhibitor drugs? *

Diarrhea

Diabetic ketoacidosis

Hypoglycemia

7. Which of the following is true about diabetic ketoacidosis with SGLT2 inhibitor treatment of diabetes in cats? *

It is most likely to occur within the first 14 days of treatment

It never occurs after 1 month of treatment

It always occurs between 18–20 days of treatment

8. SGLT2 inhibitor drugs should not be given to cats with which of the following conditions? *

Behaviour problems

Chronic pancreatitis

Food intolerance dermatitis

9. Which of the following is a feature of euglycemia diabetic ketoacidosis? *

Metabolic alkalosis

Ketonemia

Hyperglycemia

10. Which of the following is necessary for successful treatment of feline diabetes with SGLT2 inhibitor drugs? *

Sufficient endogenous insulin

Elevated pancreatic lipase

Normal serum fructosamine